Selected Start-Ups (11/04)
Executive Summary
In Vivo briefly summarizes the technologies of these recently founded companies: Cynexus, Nitec Pharma, PanOpsys, QRG Bioscience, RiboNovix and SensiGen.
You may also be interested in...
FDA Revokes Second COVID-19 Diagnostic EUA Over Performance Concerns
Autobio’s test reportedly only correctly identified half the positive COVID-19 samples in an NIH evaluation.
US GAO Review Of FDA’s OTC Drug Oversight Signals Waiting For Monograph Reform Benefits
Benefits of OTC monograph reform legislation passed in March likely will take at least several years, according to GAO report to Congress. It notes the FDA still is analyzing the legislation and it may need two years to add and train staff.
Internal US FDA Disagreements Feature In One-Quarter Of Novel Approvals
A team led by Dalhousie University researchers examined 174 novel approvals from 2011-2015 and found 155 instances of disagreement, affecting 42 drugs.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports